Hormone Therapy Clinical Trials

4 actively recruiting trials across 2 locations

▼ -1 trial since July 2026

Also known as: Chemotherapy-Hormones/Steroids, Endocrine Therapy, Hormonal, Hormonal Systemic Therapy, Hormonal Therapy +3 more

Pipeline

Phase 2: 2Phase 3: 2

Top Sponsors

University of Washington1
Sven Löffeler1
M.D. Anderson Cancer Center1
David Palma1

Indications

Cancer4
Breast Cancer2
Early Stage HER2-Positive Breast Carcinoma1
Metastatic Hormone Receptor-Positive Breast Carcinoma1
Early Stage Triple-Negative Breast Carcinoma1

Other2 trials

A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.

Phase 3

Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer

Phase 3

Houston, Texas1 trial

Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

M D Anderson Cancer Center

Phase 2

Seattle, Washington1 trial

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

Fred Hutch/University of Washington Cancer Consortium

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.